Synthesis of a four-amino-acid peptide, Amino acids 39–42 (Leu-Asp-Phe-Ile) (LDFI), based on the wild-type sequence of leptin-binding site I, has been shown to inhibit breast cancer growth in vitro and in vivo [173]. The gene discussed is LEP; the disease is breast carcinoma.